Noha Samir Abdellatif <br/><br/>
Antifibrotic potential of a selective COX-2 inhibitor (celecoxib) and a synthetic PPAR y ligand (pioglitazone) on liver fibrosis in Rats /  
 التأثير المحتمل لمثبط كوكس ٢ الإنتقائى (سيليكوكسيب) و منشط ببار جاما الإصطناعي (بيوجليتازون) علي تليف الكبد في الجرذان 
Noha Samir Abdellatif ; Supervised Ahmed Hussein Galal , Fatma Ahmed Elbatrawi , Essam Fouad Alalkamy 
 - Cairo :   Noha Samir Abdellatif ,   2011 
 - 154 P. :   charts , facsimiles ;   25cm 
<br/><br/>Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pharmacology 
<br/><br/> Chronic liver injury, independent of the cause, is generally associated with the accumulation of matrix proteins, a process referred to as fibrosis. Over the last decade liver fibrosis is no longer viewed as either passive or permanent but as a dynamic process and potential therapies continue to be identified. Hepatic stellate cells (HSCs) play a critical role in the fibrogenesis of liver, so they are the target cells of antifibrotic therapy 
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>Liver fibrosis Pioglitazone Thioacetamide